| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |